Overview

Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify, prior to prescribing, which neuropathic pain patients will benefit from duloxetine more specific the investigators aims are to: - Verify whether presence of chronic pain alters the pain modulation mechanisms, such as DNIC (diffuse noxious inhibitory control) and TS (temporal summation). - Investigate whether anti-neuropathic medications such as duloxetine indeed change the pain modulation profile, and whether this profile change is associated with a reduction of clinical pain.
Phase:
N/A
Details
Lead Sponsor:
Rambam Health Care Campus
Collaborator:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride